reports
- Kristoffer Inton
Morningstar | FDA Cracks Down on Curaleaf’s CBD Marketing but No Lon...
On July 22, the Food and Drug Administration sent a warning letter to Curaleaf regarding the marketing of its CBD products. The FDA stated that Curaleaf’s CBD products, including lotions, tinctures, pain-relief patches, and animal treatments are unapproved and misbranded drugs. Drugs can only be approved by the FDA, which it has not done for Curaleaf’s products. In addition, the FDA claimed Curaleaf is marketing with unsubstantiated therapeutic claims that the products can treat serious dise...
- Kristoffer Inton
FDA Cracks Down on Curaleaf’s CBD Marketing but No Long-Term Impact;...
On July 22, the Food and Drug Administration sent a warning letter to Curaleaf regarding the marketing of its CBD products. The FDA stated that Curaleaf’s CBD products, including lotions, tinctures, pain-relief patches, and animal treatments are unapproved and misbranded drugs. Drugs can only be approved by the FDA, which it has not done for Curaleaf’s products. In addition, the FDA claimed Curaleaf is marketing with unsubstantiated therapeutic claims that the products can treat serious dise...
- Kristoffer Inton
Morningstar | Curaleaf Expands U.S. Footprint With Acquisition of Gras...
On July 17, Curaleaf announced the acquisition of U.S. cannabis company Grassroots for $875 million, $800 million of which will be paid in equity. On a pro forma basis, Grassroots shareholders will own about 16% of the combined company. Grassroots is a privately held, verticalized multi-state cannabis operator, and the acquisition will expand Curaleaf’s footprint to the Midwest. Grassroots generated $28 million of revenue in 2018 and $12 million in the first quarter of 2019 alone. Combined wi...
- Kristoffer Inton
Morningstar | Curaleaf Expands U.S. Footprint With Acquisition of Gras...
On July 17, Curaleaf announced the acquisition of U.S. cannabis company Grassroots for $875 million, $800 million of which will be paid in equity. On a pro forma basis, Grassroots shareholders will own about 16% of the combined company. Grassroots is a privately held, verticalized multi-state cannabis operator, and the acquisition will expand Curaleaf’s footprint to the Midwest. Grassroots generated $28 million of revenue in 2018 and $12 million in the first quarter of 2019 alone. Combined wi...
- Kristoffer Inton
Curaleaf Expands U.S. Footprint With Acquisition of Grassroots at Good...
On July 17, Curaleaf announced the acquisition of U.S. cannabis company Grassroots for $875 million, $800 million of which will be paid in equity. On a pro forma basis, Grassroots shareholders will own about 16% of the combined company. Grassroots is a privately held, verticalized multi-state cannabis operator, and the acquisition will expand Curaleaf’s footprint to the Midwest. Grassroots generated $28 million of revenue in 2018 and $12 million in the first quarter of 2019 alone. Combined wit...
- Kristoffer Inton
Initiating on Fast-Growing Cannabis Industry: We See Curaleaf as Under...
We are initiating coverage of cannabis, an industry we forecast to grow by 9 times through 2030 amid widening legalization and increased participation for the Canadian, international, and U.S. markets. For Canada, despite recent recreational legalization, cannabis has penetrated just 12% of our estimated market, setting the stage for 20% CAGR through 2030. For the international market, we forecast market potential of nearly $43 billion and 23% CAGR through 2030 as more and more countries recogni...
- Kristoffer Inton
Curaleaf Provides Investors Pure-Play Exposure to the U.S., the Most A...
Curaleaf cultivates and sells cannabis in the U.S. with a presence in 15 states, including the acquisition of Cura Select. Unlike the Canadian cannabis producers, Curaleaf is much more vertically integrated with 12 cultivation sites, 19 processing sites, and 44 dispensaries. Furthermore, it gives investors full exposure to the U.S. cannabis market, the fastest growing and largest potential market.Curaleaf has developed its operating footprint focusing on states with large populations and limited...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.